Human papillomavirus vaccination in Africa

The Lancet

Volumn 378, Issue 9788, 2011, Pages 315-316

  Ouedraogo, Nobila ^a   Müller, Olaf ^a   Jahn, Albrecht ^a   Gerhardus, Ansgar ^b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY OF BREMEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

WART VIRUS VACCINE;

AFRICA; COST EFFECTIVENESS ANALYSIS; HUMAN; LETTER; MEASLES; PREVENTIVE MEDICINE; PRIORITY JOURNAL; SCREENING TEST; TETANUS; UTERINE CERVIX CANCER; VACCINATION; VACCINE PRODUCTION;

EID: 79960731605     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(11)61164-1     Document Type: Letter

References (5)

1. The Lancet Financing HPV vaccines in developing countries Lancet 377 2011 1544
2. AD Lopez, CD Mathers, M Ezzati, DT Jamisson, CJL Murray Global burden of disease and risk factors 2006 World Bank and Oxford University Press Washington, DC, and New York
3. A Gerhardus, O Razum A long story made too short: surrogate variables and the communication of HPV vaccine trial results J Epidemiol Community Health 64 2010 377 378
4. FT Cutts, S Franceschi, S Goldie et al. Human papillomavirus and HPV vaccines: a review Bull World Health Organ 85 2007 9
5. SJ Goldie, M O'Shea, NG Campos, M Diaz, S Sweet, SY Kim Health and economic outcomes of HPV 16,18 vaccination in 72 GAVI-eligible countries Vaccine 26 2008 4080 4093